RELATED CONTENT
NEWS
- US high court allows securities fraud lawsuit over Merck & Co's Vioxx
- Merck & Co challenge to Vioxx securities lawsuit gets US high court hearing next week
- Merck & Co may pay $80 million to settle more Vioxx claims
- US high court allows securities fraud lawsuit over Pfizer's Celebrex
ANALYSIS
- Executive Briefing – Health technology assessment: a brief look at the EU
- Executive Briefing – Brazil emerges as a saviour for pharma
COMMENT
Other Informa Comment
FEATURES
- Interview: Croatia's state insurer changes its role to raise efficiency
- European generics industry throws its weight behind IMPACT


